sales@scalarmarketresearch.com |  +1-800-213-5170  (U.S./ Canada Toll-free) |  REGISTER |  SIGN IN

Home >> Reports >> insomnia market

report

Insomnia Market, by Types of Therapy (Pharmacological Therapy, Non Pharmacological Therapy), Drug Formulation (Capsules, Tablet, Others) Diseases Condition (Poor Quality of Sleep, Sleep Maintenance, Other) – Global Revenue, Trends, Growth, Share, Size, and Forecast to 2022

HC353 August 2017 100+ FREE 10% CUSTOMIZATION

Insomnia is a sleep disorder wherein the person finds difficulty in sleeping or to remain asleep. Person suffers from improper sleep patterns and feels irritated, experiences low stamina, depression and sleepiness in daytime. Insomnia is caused due to various biological, behavioral and psychological reasons such as unrhythmic heartbeat, hyperthyroidism, menopause, stress and other similar medical conditions. It affects ladies more during conditions like pregnancy, postpartum and menopause. It affects millions of people worldwide and due to changes in lifestyle and other chronic problems this number is increasing every year. This report studies the current and future aspects of insomnia market.

The report on the global Insomnia market uses the top-down and bottom-up approaches to define, analyze, and describe the market trends for the next five years. The report also tracks the emerging applications, innovative technologies, and mergers & acquisitions. It also focuses on the growth drivers and restraints for the key market players during the forecast period.

KEY BENEFITS OF THE REPORT

  • In-depth analysis of the market ecosystem and its impact on the revenue growth
  • Understanding of the strategies that are being adopted by the key players in this market to stay competitive
  • Valuable insights into the key technological and market trends impacting this market

KEY PREMIUM INDUSTRY INSIGHTS

  • The insomnia market is bound to increase worldwide because of changes in lifestyle, increase in stress at workplace, changes in work shifts, rise in the number of people suffering from insomnia, and rise in chronic diseases. The advancement in technology is another market driving factor that is helping to explore the untapped markets creating growth opportunities for the insomnia market.
  • In addition, the rise in demand for insomnia treatment options is boosting the market growth. Pharmaceutical companies are collaborating to find out newer treatment options and contributing towards the progress of the market.
  • However, the side effect of drugs for insomnia is hampering the growth of the market worldwide. Moreover, the process of patent creation and the regulations are also acting as a major market restraint.

The insomnia market is divided into four major geographical segments which are North America, Europe, Asia-Pacific, and Rest of the world. The North America region holds the highest market share and is the largest revenue contributor of the insomnia market. The region continues to dominate the global market due to emergence of new technologies and new treatments for insomnia. Next in line is the Europe region which is witnessing steady growth in the insomnia market during the forecasted period because of increase in stress. Asia-Pacific region has the least market share worldwide.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s insomnia market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the insomnia market by the following segments:

  • Insomnia Market, by Types of Therapy
    • Pharmacological Therapy
    • Non Pharmacological Therapy
  • Insomnia Market, by Drug Formulation
    • Capsules
    • Tablet
    • Others
  • Insomnia Market, by Diseases Condition
    • Poor Quality of Sleep
    • Sleep Maintenance
    • Other

KEY MARKET PLAYERS

Key players in the insomnia market include:

  • Eisai, co.
  • Merck & co inc
  • Sanofi
  • Takeda Pharmaceutical Company
  • Pfizer, Inc.

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

  • NORTH AMERICA
    • U.S.
    • Rest of North America
  • EUROPE
    • France
    • Germany
    • U.K
    • Rest of Europe
  • ASIA-PACIFIC
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • REST OF THE WORLD
    • Latin America
    • Middle East & Africa

TRENDING RELATED REPORT

Neurostimulation Market, by Therapies (Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation and Vagus Nerve Stimulation) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022


  1. MARKET OVERVIEW
    1. Market Definitions
    2. Research Methodology
    3. Market Segmentation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Premium Industry Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
  5. INSOMNIA MARKET, BY TYPES OF THERAPY
    1. Segment Share
    2. By Types of Therapy
      1. Pharmacological Therapy
      2. Non Pharmacological Therapy
  6. INSOMNIA MARKET, BY DRUG FORMULATION
    1. Segment Share
    2. By Drug Formulation
      1. Capsules
      2. Tablet
      3. Others
  7. INSOMNIA MARKET, BY DISEASES CONDITION
    1. Segment Share
    2. By Diseases Condition
      1. Poor Quality of Sleep
      2. Sleep Maintenance
      3. Other
  8. INSOMNIA MARKET, BY GEOGRAPHY
    1. Segment Share
    2. North America
      1. By Regions
        1. U.S.
        2. Rest of North America
      2. By Type of Therapy
      3. By Drug Formulation
      4. By Diseases Condition
    3. Europe
      1. By Regions
        1. France
        2. Germany
        3. U.K.
        4. Rest of Europe
      2. By Type of Therapy
      3. By Drug Formulation
      4. By Diseases Condition
    4. Asia-Pacific
      1. By Regions
        1. China
        2. India
        3. Japan
        4. Rest of Asia-Pacific
      2. By Type of Therapy
      3. By Drug Formulation
      4. By Diseases Condition
    5. Rest of the World
      1. By Regions
        1. Latin America
        2. Middle East & Africa
      2. By Type of Therapy
      3. By Drug Formulation
      4. By Diseases Condition
  9. COMPETITIVE LANDSCAPE
    1. Market Positioning of Key Players, 2016
  10. KEY MARKET PLAYERS
    1. Eisai, co.
      1. Overview
      2. Key Strategies
      3. Key Developments
    2. Merck & co Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    3. Sanofi
      1. Overview
      2. Key Strategies
      3. Key Developments
    4. Takeda Pharmaceutical Company
      1. Overview
      2. Key Strategies
      3. Key Developments
    5. Pfizer, Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
  11. SCALAR 360 DEGREE MARKET PERSPECTIVE
  12. APPENDIX
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170

EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

Unparalleled Expertise

Our industry experts hold inimitable know-how across wide range of industry verticals

Assured Quality

We deliver high-quality, real-time and data-driven industry insights to our clients

24x7 Analyst Support

We offer pre-purchase and post-purchase support from our industry experts

Privacy & Security

All your personal information and confidential details are safe and secure with us